Cite
Mattsson N, Carrillo MC, Dean RA, et al. Revolutionizing Alzheimer's disease and clinical trials through biomarkers. Alzheimers Dement (Amst). 2015;1(4):412-9doi: 10.1016/j.dadm.2015.09.001.
Mattsson, N., Carrillo, M. C., Dean, R. A., Devous, M. D., Nikolcheva, T., Pesini, P., Salter, H., Potter, W. Z., Sperling, R. S., Bateman, R. J., Bain, L. J., & Liu, E. (2015). Revolutionizing Alzheimer's disease and clinical trials through biomarkers. Alzheimer's & dementia (Amsterdam, Netherlands), 1(4), 412-9. https://doi.org/10.1016/j.dadm.2015.09.001
Mattsson, Niklas, et al. "Revolutionizing Alzheimer's disease and clinical trials through biomarkers." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 1,4 (2015): 412-9. doi: https://doi.org/10.1016/j.dadm.2015.09.001
Mattsson N, Carrillo MC, Dean RA, Devous MD, Nikolcheva T, Pesini P, Salter H, Potter WZ, Sperling RS, Bateman RJ, Bain LJ, Liu E. Revolutionizing Alzheimer's disease and clinical trials through biomarkers. Alzheimers Dement (Amst). 2015 Oct 03;1(4):412-9. doi: 10.1016/j.dadm.2015.09.001. eCollection 2015 Dec. PMID: 27239522; PMCID: PMC4879481.
Copy
Download .nbib